Table 2.
GC-MS analysis of WGF-EO and CGF-EO.
| RT (min) | Compound name | Composition (%)a | |
|---|---|---|---|
| WGF-EO | CGF-EO | ||
| 8.16 | Trans 3-hexen-1-ol | 0.07 | 0.05 |
| 8.67 | 2-Hexenal | 0.05 | 0.28 |
| 12.83 | Beta-terpineol acetate | — | 0.03 |
| 12.85 | D-Limonene | — | 0.03 |
| 13.89 | Eucalyptol | 0.05 | — |
| 16.76 | Beta-linalool | 0.02 | 0.01 |
| 17.33 | 2-Myristynonyl pantetheine | — | 0.02 |
| 20.57 | 4-Terpineol | 0.01 | — |
| 21.51 | 5,8,11-heptadecatrien-1-ol | 0.02 | 0.01 |
| 23.59 | Methyl salicylate | 97.85 | 99.38 |
| 25.71 | Ethyl salicylate | — | 0.03 |
| 29.13 | Phenol 2-methoxy-3-2 propenyl | 0.98 | — |
| 29.40 | Trans-m-propenyl guaicol | — | 0.04 |
| 29.81 | Beta-curcumene | 0.08 | — |
| 30.84 | 7-Epi cis sesquisabinene | 0.01 | — |
| 34.84 | 6-Epi shyobunol | 0.01 | — |
| 35.31 | Eugenol | 0.60 | — |
RT, retention time (minutes).
Components present in EOs at greater than 0.2% are indicated by bold font.
aPercentages were calculated based on normalized FID peak areas.